France reimbursement relisting for embolisation devices
This article was originally published in Clinica
Executive Summary
Manufacturers and distributors of a series of arterial embolisation implants that are already on the list of devices reimbursed when used in the private healthcare sector in France must now reapply for listing or lose their market.